Neurotrope (SNPX) - Sotuvning sof marjinal rentabelligi

Neurotrope (SNPX) tovar belgisi

Synaptogenix, Inc. (SNPX) ko'p yillik talabga tayanib, miya degeneratsiyasiga qarshi davolash vositalarini ishlab chiqmoqda. Tarixiy savdo marjalari ushbu kutishlarni vizuallashtiradi, bunda 0.00 belgisi samaradorlikning joriy darajasini ko'rsatadi. Bahsli test natijalari tufayli jamoa hozirda resurslarni qat'iy ravishda tejamoqda, garchi olimlar bemorlar xotirasini to'liq tiklash uchun ularning sinapslarni regeneratsiya qilish usulini yuqori baholasalar-da.

SNPX: synaptogen.com Sotuvning sof rentabelligi 04.07.2022 - 02.05.2026

Synaptogenix, Inc (SNPX) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:Synaptogenix Inc. - SNPX
Neurotrope yetakchi tovari

Synaptogenix, Inc. (SNPX) kompaniyasining fundamental tahlili investitsiya risklarini minimallashtirish uchun operatsion xarajatlarning qat'iy nazoratini talab qiladi. Altsgeymer kasalligi davolash vositalarini ishlab chiqishning o'ziga xos xususiyatlari patent daromadlarini olishdan oldin uzoq muddatli investitsiya davrini nazarda tutadi. Sof marja dinamikasida aks etgan sof rentabellik, barcha xarajatlar chegirilgandan keyin har bir dollar daromadning qancha qismi foyda ekanligini o'lchaydi. Manfiy qiymatlar biznesning joriy bosqichi zararli ekanligidan dalolat beradi. Ushbu ko'rsatkich kompaniyaning kapital barqarorligini ob'ektiv baholash imkonini beradi.

Asosiy raqobatchilar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Kompaniya sotuv marjasi Cyclerion Therapeutics (CYCN)|Protagenic - Sotuvning sof marjinal rentabelligi|Sof foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Sotuvning sof marjinal rentabelligi|Avenue Therapeutics Inc. (ATXI) - Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Cara Therapeutics Inc|Sof marja Chromocell Therapeutics (CHRO)|Kompaniyaning sof rentabelligi ELYM|Sof marja Intra-Cellular ITCI|LBPH: Sotuvning sof rentabelligi|MRNS - Sof marja|NKGen Biotech, Inc. (NKGN) - Sof foyda bo'yicha sotuv rentabelligi|neurobopharma.com (NRBO) - Sof marja|SAGE: Kompaniyaning sof rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel